Stigma keeps many cancer patients from using a service that offers much-needed help to the sick as well as the dying
April 26, 2017
| By Diane Mapes / Fred Hutch News Service
Palliative care isn't just about easing suffering at end of life. It’s also appropriate for patients dealing with pain or side effects anywhere along the cancer continuum. But not all patients, or doctors, realize this. Two Fred Hutch experts discuss the latest research, and the stigma, surrounding this crucial type of care.
Research symposium and ribbon cutting celebrates first-of-its-kind facility for experimental immunotherapies
Dec. 16, 2016
| By Susan Keown / Fred Hutch News Service
Lymphoma survivor Stephanie Florence said she wouldn't be alive if not for the science done at Fred Hutchinson Cancer Research Center. This week, she cut the ribbon at the grand opening of the Bezos Family Immunotherapy Clinic, which will make it possible for twice as many patients like Florence to receive treatment.
A drug with a storied past offers a new edge against an old foe
Dec. 4, 2016
| By Sabin Russell / Fred Hutch News Service
Discovered nearly 45 years ago in the volcanic soils of fabled Easter Island in the Pacific, a drug first thought of as an antifungal agent has found a new purpose by boosting the survival of leukemia patients after blood stem cell transplants. In a clinical trial conducted by Fred Hutchinson Cancer Research Center, the addition of a third drug, sirolimus, to a standard two-drug regimen effectively cut in half the incidence of acute graft-vs.-host disease, or GVHD, a common and dangerous complication of these lifesaving procedures.